Public SEC Form D records
Biotech Series A Form D filings - August 2026
This page lists the 44 matching Form D filings FormDFlow has indexed and tagged from public SEC EDGAR records for Biotech-tagged issuers at a FormDFlow-inferred Series A stage in August 2026 - a filtered subset, not every matching Form D filed, and not a ranked, curated, or recommended selection. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.
- Filings
- 44
- Issuers
- 41
- Combined disclosed
- $258.7M
Directory links
Filing records
44 crawlable filing links in this facet.
- Plowshare Therapies LLCAugust 31, 2026 / Reg D 506(b) / PA$6.7M
- DalCor Pharmaceuticals US, LLCAugust 28, 2026 / Reg D 506(b) / FL$7.0M
- Aegle Therapeutics CorpAugust 28, 2026 / Reg D 506(b) / MA$2.3M
- FluidForm Bio, Inc.August 27, 2026 / Reg D 506(b) / MA$3.0M
- J3 BIOSCIENCE, INC.August 27, 2026 / Reg D 506(b) / UT$2.8M
- Noveome Biotherapeutics, Inc.August 27, 2026 / Reg D 506(b) / PA$15.0M
- Bioliberty LtdAugust 27, 2026 / Reg D 506(b)$2.9M
- Platform Therapeutics, Inc.August 27, 2026 / Reg D 506(b) / MA$4.0M
- Forecast Bio, Inc.August 27, 2026 / Reg D 506(b) / CA$3.1M
- Aptevo Therapeutics Inc.August 26, 2026 / Reg D 506(c) / WA$3.5M
- ProEncia Biotechnology Inc.August 26, 2026 / Reg D 506(b) / MN$2.0M
- Codebreaker Tx, Inc.August 26, 2026 / Reg D 506(b) / CO$7.4M
- OS Therapies IncAugust 25, 2026 / Reg D 506(b) / MD$10.0M
- Axiom Therapeutics Inc.August 25, 2026 / Reg D 506(b) / DE$12.3M
- MalarVx, Inc.August 25, 2026 / Reg D 506(b) / WA$2.5M
- NewcelX Ltd.August 24, 2026 / Reg D 506(b)$2.9M
- Unravel Biosciences, Inc.August 24, 2026 / Reg D 506(b) / MA$4.5M
- PathFinder CRO, IncAugust 24, 2026 / Reg D 506(b) / FL$2.0M
- AlloTRx Bio Inc.August 24, 2026 / Reg D 506(b) / PA$3.0M
- NOVIR, INC.August 20, 2026 / Reg D 506(b) / WI$4.0M
- Dare Bioscience, Inc.August 20, 2026 / Reg D 506(b) / CA$12.4M
- LifeCyte Innovations, Inc.August 20, 2026 / Reg D 506(b) / GA$5.0M
- Apollomics Inc.August 19, 2026 / Reg D 506(b) / CA$10.0M
- Aer Therapeutics, Inc.August 19, 2026 / Reg D 506(b) / NC$3.0M
- Fareon, Inc.August 19, 2026 / Reg D 506(b) / CA$11.4M
- InnovoTEX Inc.August 18, 2026 / Reg D 506(b) / TX$4.0M
- Strella Biotechnology, Inc.August 14, 2026 / Reg D 506(b) / WA$3.3M
- Maxona Pharmaceuticals, Inc.August 14, 2026 / Reg D 506(b) / PA$12.0M
- Auron Therapeutics, Inc.August 13, 2026 / Reg D 506(b) / MA$12.0M
- HYKU BIOSCIENCES INC.August 13, 2026 / Reg D 506(b) / MA$8.6M
- BTB Therapeutics, Inc.August 12, 2026 / Reg D 506(b) / CA$10.4M
- Grace Therapeutics, Inc.August 11, 2026 / Reg D 506(b) / NJ$10.0M
- InSitu Biologics, Inc.August 10, 2026 / Reg D 506(b) / MN$2.5M
- Voyageur Pharmaceuticals Ltd.August 10, 2026 / Reg D 506(b)$4.8M
- Convexity Scientific Inc.August 7, 2026 / Reg D 506(b) / CT$2.9M
- Convexity Scientific Inc.August 7, 2026 / Reg D 506(b) / CT$13.0M
- Duo Oncology Inc.August 7, 2026 / Reg D 506(b) / PA$3.5M
- BioGene Therapeutics Inc.August 7, 2026 / Reg D 506(b) / TX$3.0M
- Layka Bio IncAugust 7, 2026 / Reg D 506(b) / MA$5.0M
- Cerium Pharmaceuticals, Inc.August 6, 2026 / Reg D 506(b) / MD$2.5M
- InnovoTEX Inc.August 6, 2026 / Reg D 506(b) / TX$4.0M
- BioGene Therapeutics Inc.August 6, 2026 / Reg D 506(b) / TX$3.0M
- Insignis Therapeutics Inc.August 5, 2026 / Reg D 506(b) / CT$8.5M
- Hepion Pharmaceuticals, Inc.August 5, 2026 / Reg D 506(b) / NJ$3.1M